Headline News about Mirum Pharmaceuticals Inc![]() ![]() Via Benzinga
![]() ![]()
The Latest Analyst Ratings for Mirum Pharmaceuticals
June 15, 2023
Via Benzinga
![]() Via Talk Markets
![]() Via Benzinga
![]()
Mirum Pharmaceuticals: Q1 Earnings Insights
May 04, 2023
Via Benzinga
![]()
Analyst Expectations for Mirum Pharmaceuticals's Future
April 06, 2023
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]()
Analyst Expectations for Mirum Pharmaceuticals's Future
March 09, 2023
Via Benzinga
![]()
Earnings Preview: Mirum Pharmaceuticals
March 07, 2023
Via Benzinga
Mirum Pharmaceuticals's Return On Capital Employed Insights
December 14, 2022
Via Benzinga
![]()
Europe Approves Mirum Pharma's Drug For Rare Genetic Liver Disease
December 13, 2022
Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022
September 01, 2022
Via Benzinga
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|